Congenica
UKWho owns Congenica?
Congenica is a British HealthTech company, now owned by SeqOne, which acquired it in 2025 from Amadeus Capital Partners, Cambridge Innovation Capital and Parkwalk Advisors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Fully exited in 2025 to SeqOne.
- ·Average hold across 3 realized cycles: 10 years.
Ownership history
3 ownership periods · co-invest detected
Amadeus Capital Partners sold Congenica to SeqOne in 2025 after 11 years.
Cambridge Innovation Capital sold Congenica to SeqOne in 2025 after 10 years.
Parkwalk Advisors sold Congenica to SeqOne in 2025 after 8 years.
More from CIC Fund II
Other portfolio companies in the same fund.
More PE-backed in HealthTech
Comparable healthtech deals from other GPs.
US
Questions
Who owns Congenica?
Congenica is now owned by SeqOne, which acquired it in 2025 from Amadeus Capital Partners, Cambridge Innovation Capital and Parkwalk Advisors.
When did SeqOne acquire Congenica?
SeqOne acquired Congenica in 2025, buying from Amadeus Capital Partners, Cambridge Innovation Capital and Parkwalk Advisors.
Who did Congenica sell to?
Amadeus Capital Partners, Cambridge Innovation Capital and Parkwalk Advisors sold Congenica to SeqOne in 2025 (Trade Sale).
Who has owned Congenica over time?
Congenica has been through 3 private-equity ownership periods: Amadeus Capital Partners · via Amadeus IV Digital Prosperity Fund · 2014–2025 · sold to SeqOne · (Trade Sale); Cambridge Innovation Capital · via CIC Fund II · 2015–2025 · sold to SeqOne · (Trade Sale); Parkwalk Advisors · via Parkwalk Opportunities EIS Fund · 2017–2025 · sold to SeqOne · (Trade Sale).